5 Companies Boosting Their Dividend by at Least 200% in the 1st Quarter
Sean Williams, The Motley Fool - Motley Fool - 1 hr 46 mins ago
It certainly doesn't feel like it, given the near record number of share buybacks ongoing and the relatively low payout ratios for S&P 500 companies, but the first quarter of 2014 was a record quarter for income investors. Source: ...
Even With A Change At The Top, Danaher Corporation Will Roll On
Stephen D., Simpson,, The Motley Fool - Motley Fool - Thu Apr 17, 5:30PM CDT
Multi-industry conglomerate Danaher definitely buried the lede this quarter, as news of the unexpected retirement of well-liked CEO H. Lawrence Culp next year overshadowed an otherwise "OK ... but not great" quarter. Losing a good CEO is also a...
Why Danaher (DHR) Stock Is Down Today
at The Street - Thu Apr 17, 3:24PM CDT
Danaher (DHR) second quarter guidance misses analysts estimates
Danaher CEO Change, Guidance Underwhelm Investors
at Investor's Business Daily - Thu Apr 17, 11:31AM CDT
Scientific instrument maker Danaher (DHR) was down 1.5% in heavy volume in morning trading on the stock market today after it announced a new CEO and guided Q2 a bit below consensus. Late Wednesday, Danaher released Q1 earnings and announced that CEO...
Why You Should Plug Into General Electric
at The Street - Thu Apr 17, 9:34AM CDT
At around $26 per share, GE is one of the few conglomerate bargains that are left. And CEO Immelt should be left alone to continue what he's started.
Danaher Beats on Q1 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 9:20AM CDT
Danaher Corporation (DHR) reported earnings of 81 cents a share in first-quarter 2014, which surpassed the Zacks Consensus Estimate by a penny and increased 8% from 75 cents in the prior-year quarter.
Danaher (DHR) Crosses Pivot Point Support at $73.05
Comtex SmarTrend(R) - Thu Apr 17, 9:04AM CDT
Shares of Danaher (NYSE
Danaher Reports Record First Quarter 2014 Results
PR Newswire - Wed Apr 16, 3:01PM CDT
Danaher Corporation (NYSE
Danaher Corporation Announces CEO Transition
PR Newswire - Wed Apr 16, 3:01PM CDT
Danaher Corporation (NYSE: DHR) today announced that Executive Vice President Thomas P. Joyce, Jr. will succeed H. Lawrence Culp, Jr. as President and Chief Executive Officer upon Mr. Culp's retirement on March 1, 2015. Mr. Culp will continue at Danaher in an advisory role into the first quarter of 2016.
Steve Moule Named President of Gilbarco North America
Marketwire - Wed Apr 16, 10:59AM CDT
Steve Moule has been named President of Gilbarco North America. Steve reports to Martin Gafinowitz, Danaher Senior Vice President and Group Executive for Gilbarco Veeder-Root.
Earnings Release Schedules, New Product Launches, Stock Price Updates, Call Schedule Changes, and Appointments - Caterpillar, John Deere, Cummins, Danaher, and Eaton
PR Newswire - Tue Apr 15, 7:23AM CDT
Today, Analysts Review released its analysts' notes regarding Caterpillar Inc. (NYSE:CAT), Deere & Company (NYSE
Danaher (DHR) Shares Cross Below 200 DMA
MarketNewsVideo.com - Mon Apr 14, 3:02PM CDT
In trading on Monday, shares of Danaher Corp. crossed below their 200 day moving average of $72.10, changing hands as low as $71.90 per share.
Danaher Corporation (DHR) Marked As Today's Roof Leaker Stock
at The Street - Mon Apr 14, 2:27PM CDT
Trade-Ideas LLC identified Danaher Corporation (DHR) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate
Global Molecular Spectroscopy (NMR, UV-Visible, IR, NIR, Raman) Market 2014-2018
M2 - Fri Apr 11, 9:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5g3ztn/molecular) has announced the addition of the "Global Molecular Spectroscopy (NMR, UV-Visible, IR, NIR, Raman) Market 2014-2018" report to their offering. Owing to the diverse nature of molecular spectroscopy technologies, these technologies cover a wide area of applications. The wide application of NMR spectroscopy, improvements in Raman technologies, and miniaturization of molecular spectroscopy instruments are the factors that are contributing to the growth of the market. The demand for molecular spectroscopy systems is growing, owing to the increasing requirements in the life sciences and pharmaceutical industries as wells as the substantial demand from the chemical and petrochemical industries. Moreover, the growing market for terahertz technology has resulted in the rapid growth of the market. The key factors propelling the growth of this market are increased investments, funding, and grants by government bodies worldwide; ongoing new product launches; technological advancements; increase in the number of conferences, which helps to create awareness about molecular spectroscopy techniques; growing concerns over food and drug safety; and increasing use of molecular spectroscopy techniques in the fields of proteomics, biomarkers, and metabolomics. This report broadly categorizes the global market into different technologies and applications. Based on products, the market comprises NMR Spectroscopy, Ultraviolet-Visible Spectroscopy (UV-Vis), Infrared Spectroscopy (IR), Near Infrared (NIR) Spectroscopy, Color Measurement Spectroscopy, Raman Spectroscopy, and others. The NMR Spectroscopy segment includes Continuous Wave NMR spectroscopy, Fourier Transform NMR spectroscopy, Solid-State NMR spectroscopy, and others. The Ultraviolet-Visible Spectroscopy (UV-Vis) segment comprises Single-beam UV-vis spectroscopy, Dual-beam UV-vis spectroscopy, Array-based UV-vis spectroscopy, handheld UV-vis spectroscopy, and others. The Infrared Spectroscopy (IR) market is further segment into market by spectrum and market by technology. The IR market by spectrum includes short-wave Infrared spectroscopy, mid-wave Infrared spectroscopy, and far-wave Infrared spectroscopy. The IR market by technology includes markets for benchtop, hyphenated, microscopy, portable, and terahertz spectroscopy. The Raman spectroscopy market is segmented by sampling technique and by technology. NMR spectroscopy accounted for the largest share of the overall molecular spectroscopymetry market, by technology, followed by UV-VIS spectroscopy. However, the Raman spectroscopy segment is expected to grow at the highest CAGR from 2013 to 2018. This high growth can be attributed to its technological advancements, and growing adoption in the pharmaceutical industry. Based on applications, the market is segmented into pharmaceuticals, biotechnology & biopharmaceuticals, food & beverage testing, environmental testing, academic research institutes, and others. Based on geography, the market is divided into North America, Europe, Asia, and the Rest of World (RoW). North America is the largest market for molecular spectroscopy, followed by Europe and Asia. However, the Asian market is slated to grow at the highest rate over the next five years. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 By Technology 5 By Application 6 By Geography 7 Competitive Landscape 8 Company Profiles - Agilent Technologies, Inc. - Bruker - Danaher Corporation - Foss - Jasco, Inc. - Jeol Ltd. - Perkinelmer, Inc. - Shimadzu Corporation - The Abb Group - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/5g3ztn/molecular
Global High Throughput Screening (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics) Market 2014-2018
M2 - Fri Apr 11, 6:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wnx4xn/high_throughput) has announced the addition of the "High Throughput Screening (HTS) Market by Technology, Applications & by End Users - Forecast to 2018" report to their offering. The global HTS market was valued at $13,736 million in 2013 and is expected to reach $19,627 million by 2018, at a CAGR of 7.4% In recent years, the high throughput screening (HTS) market has witnessed a large number of technological advancements, which has resulted in an increase in the rate of adoption of HTS in laboratories. . The HTS market is broadly classified into five segments, namely, technologies, products, applications, end users, and geography. The technology market is sub-divided into ultra high throughput screening, cell-based assays, lab-on-a chip, label-free technology, and bioinformatics. The cell-based assays segment dominated the HTS market in 2013, followed by the lab-on-a-chip segment. The HTS products market is broadly categorized into instruments, consumables/reagents, and software and services. The consumables/reagents segment dominated this market in 2013, with a market share of around 57%. The applications market is segmented into target identification, primary screening, toxicology, stem cell biology, and others. Target identification dominated the HTS applications market in 2013, followed by the primary screening market. The HTS market by end user is broadly categorized into pharmaceutical companies, biotechnology companies, academic and government institutes, contract research organizations (CROs), and others. The pharmaceuticals segment dominated the market in 2013, with a market share of around 48%. The major factors driving the growth of the HTS market are technological innovations, open innovation models adopted by pharmaceutical companies, increasing drug discovery initiatives by academic institutions, and huge capital investments in HTS technology by organizations. Moreover, the presence of a large untapped market in emerging countries and growth in outsourcing of drug discovery services especially in China and India are the various factors that are expected to provide growth opportunities for players in this market. However, the capital intensive nature of HTS and difficulties in assay development for novel target classes are the factors curbing the growth of this market. Company Profiles - Agilent Technologies, Inc. - Aurora Biomed - Axxam Spa - Beckman Coulter, Inc. (A Subsidiary Of Danaher) - Bio-Rad Laboratories - Biofocus Dpi Ltd. - Intellicyt Corporation - Luminex Corporation - Perkinelmer, Inc. - Sigma Aldrich Corporation - Tecan Group Ltd. - Thermo Fisher Scientific, Inc. Scope of the Report Technology - Cell-Based Assay - Ultra high throughput screening (uHTS)Lab-on-a-chip - Label Free Technology - Bioinformatics Product - Instruments - Consumables/Reagents - Software and Services Application - Target Identification - Primary Screening - Toxicology - Stem Cell Biology - Others End User - Pharmaceutical - Biotechnology - Academic & Government Organizations - Contract Research Organizations - Others For more information visit http://www.researchandmarkets.com/research/wn...throughput
Strategies for the European HIV/AIDS Diagnostic Testing Market 2014-2019
M2 - Fri Apr 11, 3:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5r89m7/2014_strategies) has announced the addition of the "2014 Strategies for the European HIV/AIDS Diagnostic Testing Market" report to their offering. This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood Banks - Public Health Laboratories For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests. Highlights - Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses. - Examines market applications of Molecular Diagnostics, Immundiagnostics, IT and other emerging technologies. - Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho- Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers. - Profiles leading manufacturers and potential market entrants developing innovative technologies and products. - Analyzes alternative market penetration strategies for suppliers. For more information visit http://www.researchandmarkets.com/research/5r...strategies
Earnings Release Dates -- Research on Cypress Semiconductor, Danaher, Fairchild Semiconductor Intl., and Dover
PR Newswire - Thu Apr 10, 10:02AM CDT
Earningsource.com provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and earnings projection for their upcoming quarterly release, our aim is to ensure shareholders and traders have an edge on their investment decisions on the following companies: Cypress Semiconductor Corp. (NASDAQ: CY), Danaher Corp. (NYSE: DHR), Fairchild Semiconductor International Inc. (NASDAQ: FCS) and Dover Corp. (NYSE: DOV). Full earnings notes on CY, DHR, FCS and DOV can be downloaded upon signing up at:
Upgrade Alert for Danaher (DHR)
Comtex SmarTrend(R) - Thu Apr 10, 7:03AM CDT
Danaher (NYSE
Will This Upgrade Help Danaher (DHR) Stock Today?
at The Street - Wed Apr 09, 8:16AM CDT
ISI Group upgrades Danaher (DHR) to 'strong buy' from 'buy,' saying the market is shifting toward high-quality, large-cap companies with solid free cash-flow.
Upcoming Events, Completion of Defense Exercise, and Stock Price Movements - Analyst Notes on Caterpillar, Northrop Grumman, Emerson, Martin Marietta, and Danaher
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Caterpillar Inc. (NYSE: CAT), Northrop Grumman Corporation (NYSE: NOC), Emerson Electric Co. (NYSE: EMR), Martin Marietta Materials Inc. (NYSE: MLM), and Danaher Corporation (NYSE: DHR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register